Added to YB: 2022-05-14
Pitch date: 2022-05-14
SWTX [bearish]
SpringWorks Therapeutics, Inc.
-21.17%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.
Market Cap
$3.5B
Pitch Price
$38.78
Price Target
N/A
Dividend
N/A
EV/EBITDA
-11.96
P/E
-13.77
EV/Sales
14.41
Sector
Biotechnology
Category
N/A
Show full summary:
SPRINGWORKS THERAPEUTICS INC SWTX
A summary for this pitch has not been created yet.
Read full article (0 min)